In Vitro Antiherpesviral Activity of 5-Alkyl Derivatives of 1-β-d-Arabinofuranosyluracil
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...
Saved in:
Published in | Antimicrobial Agents and Chemotherapy Vol. 16; no. 2; pp. 158 - 163 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
01.08.1979
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
---|---|
AbstractList | Several 5-alkyl derivatives of 1-β-
d
-arabinofuranosyluracil (araU) were tested for antiherpesviral activity and inhibitory action on cell growth in human embryonic lung fibroblasts. 1-β-
d
-Arabinofuranosylcytosine, 9-β-
d
-arabinofuranosyladenine, and 5-iododeoxyuridine (IUdR) were included as reference materials. Among the 5-alkyl derivatives of araU, arabinosylthymine was the most active, followed by 5-ethyl- and 5-propyl-araU. 5-Ethyl-araU was as active as IUdR and more active than 9-β-
d
-arabinofuranosyladenine against herpes simplex virus (HSV) type 1 and did not inhibit cell growth at a concentration as high as 1,000 μg/ml. 5-Butyl- and 5-methoxymethyl-araU, as well as araU, exhibited relatively low activity. The araU derivatives tested were as active against HSV WT-34, an isolate from a patient with keratitis, as against HSV type 1. Against an IUdR-resistant isolate, HSV WT-20, arabinosylthymine was less inhibitory than IUdR. Deoxyribonucleic acid synthesis in HSV type 1-infected cells was markedly inhibited by arabinosylthymine, IUdR, and 5-ethyl-araU, whereas cellular deoxyribonucleic acid synthesis in uninfected cells was significantly inhibited by IUdR but not by arabinosylthymine or 5-ethyl-araU. Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology. For an alternate route to AAC .asm.org, visit: AAC Several 5-alkyl derivatives of 1-β-d-arabinofuranosyluracil (araU) were tested for antiherpesviral activity and inhibitory action on cell growth in human embryonic lung fibroblasts. 1-β-d-Arabinofuranosylcytosine, 9-β-d-arabinofuranosyladenine, and 5-iododeoxyuridine (IUdR) were included as reference materials. Among the 5-alkyl derivatives of araU, arabinosylthymine was the most active, followed by 5-ethyl- and 5-propyl-araU. 5-Ethyl-araU was as active as IUdR and more active than 9-β-d-arabinofuranosyladenine against herpes simplex virus (HSV) type 1 and did not inhibit cell growth at a concentration as high as 1,000 μg/ml. 5-Butyl- and 5-methoxymethyl-araU, as well as araU, exhibited relatively low activity. The araU derivatives tested were as active against HSV WT-34, an isolate from a patient with keratitis, as against HSV type 1. Against an IUdR-resistant isolate, HSV WT-20, arabinosylthymine was less inhibitory than IUdR. Deoxyribonucleic acid synthesis in HSV type 1-infected cells was markedly inhibited by arabinosylthymine, IUdR, and 5-ethyl-araU, whereas cellular deoxyribonucleic acid synthesis in uninfected cells was significantly inhibited by IUdR but not by arabinosylthymine or 5-ethyl-araU. Several 5-alkyl derivatives of 1-beta-d-arabinofuranosyluracil (araU) were tested for antiherpesviral activity and inhibitory action on cell growth in human embryonic lung fibroblasts. 1-beta-d-Arabinofuranosylcytosine, 9-beta-d-arabinofuranosyladenine, and 5-iododeoxyuridine (IUdR) were included as reference materials. Among the 5-alkyl derivatives of araU, arabinosylthymine was the most active, followed by 5-ethyl- and 5-propyl-araU. 5-Ethyl-araU was as active as IUdR and more active than 9-beta-d-arabinofuranosyladenine against herpes simplex virus (HSV) type 1 and did not inhibit cell growth at a concentration as high as 1,000 mug/ml. 5-Butyl- and 5-methoxymethyl-araU, as well as araU, exhibited relatively low activity. The araU derivatives tested were as active against HSV WT-34, an isolate from a patient with keratitis, as against HSV type 1. Against an IUdR-resistant isolate, HSV WT-20, arabinosylthymine was less inhibitory than IUdR. Deoxyribonucleic acid synthesis in HSV type 1-infected cells was markedly inhibited by arabinosylthymine, IUdR, and 5-ethyl-araU, whereas cellular deoxyribonucleic acid synthesis in uninfected cells was significantly inhibited by IUdR but not by arabinosylthymine or 5-ethyl-araU. |
Author | Chikao Nakayama Mineo Saneyoshi Akira Kuninaka Haruhiko Machida Hiroshi Yoshino Shinji Sakata |
AuthorAffiliation | 1 Research Laboratory, Yamasa Shoyu Company Limited, Choshi 288 2 Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060, Japan |
AuthorAffiliation_xml | – name: 2 Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060, Japan – name: 1 Research Laboratory, Yamasa Shoyu Company Limited, Choshi 288 |
Author_xml | – sequence: 1 givenname: H surname: Machida fullname: Machida, H – sequence: 2 givenname: S surname: Sakata fullname: Sakata, S – sequence: 3 givenname: A surname: Kuninaka fullname: Kuninaka, A – sequence: 4 givenname: H surname: Yoshino fullname: Yoshino, H – sequence: 5 givenname: C surname: Nakayama fullname: Nakayama, C – sequence: 6 givenname: M surname: Saneyoshi fullname: Saneyoshi, M |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/485126$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ULtOwzAUtRCvFtgYGbIi4WLHteMMDFF5VarEUiExWY5rU0NqV3Za1N_iQ_gmXAXxGJiu7j0PnXv6YNd5pwE4xWiAcc4vq2o0wGyQDzDlO6CHUckhoyXbBT2EGINDjoaHoB_jC0o7LdEB2B9yinPWA09jlz3aNviscq2d67DUcW2DbLJKtXZt203mTUZh1bxumuxaB7uW6a7j9ozhxzucwSrI2jpvVkE6HzdNmso2x2DPyCbqk695BKa3N9PRPZw83I1H1QRKQjGHpM71jCBVEjw0lJlCE1RoXFCiTW2QKmpSKKwoJwhRzRChCBc1NbRGvOSEHIGrzna5qhd6prRrU3qxDHYhw0Z4acVfxNm5ePZrQWjO8VZ_0elV8DEGbb6lGIltvSLVKzATuUj1Jvp5R5dxkYsXvwouPfcf9-x3tG_jrvsEZx08t8_zNxu0SJ5CSvXj8AnbIZAk |
CitedBy_id | crossref_primary_10_1080_07328318208078828 crossref_primary_10_3987_COM_06_10869 crossref_primary_10_1016_0166_3542_82_90044_4 crossref_primary_10_1007_BF01880663 crossref_primary_10_1016_j_carres_2011_07_026 crossref_primary_10_1016_0163_7258_80_90034_0 crossref_primary_10_1007_BF01145807 crossref_primary_10_1016_0166_3542_87_90084_2 crossref_primary_10_1016_0166_1280_94_80140_1 crossref_primary_10_1016_j_bmc_2007_06_058 crossref_primary_10_1016_j_tet_2008_08_014 crossref_primary_10_1002_prac_19843260618 crossref_primary_10_1016_0166_3542_84_90030_5 crossref_primary_10_3987_COM_06_S_K_50 crossref_primary_10_1016_0166_3542_83_90024_4 crossref_primary_10_3987_COM_08_S_N_50 |
ContentType | Journal Article |
Copyright | Copyright © 1979, American Society for Microbiology |
Copyright_xml | – notice: Copyright © 1979, American Society for Microbiology |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM |
DOI | 10.1128/AAC.16.2.158 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology Biology Chemistry |
EISSN | 1098-6596 |
EndPage | 163 |
ExternalDocumentID | 10_1128_AAC_16_2_158 10.1128/AAC.16.2.158 485126 aac_16_2_158 |
Genre | Journal Article |
GroupedDBID | --- .55 .GJ 0R~ 23M 2WC 39C 3O- 4.4 53G 5GY 5RE 5VS 6J9 ACGFO ADBBV AENEX AGNAY AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CGR CS3 CUY CVF DIK E3Z EBS ECM EIF EJD F5P FRP GX1 H13 HH5 HYE HZ~ H~9 J5H K-O KQ8 L7B LSO MVM NEJ NPM O9- OK1 P2P RHF RHI RNS RPM RSF TR2 UHB VH1 W2D W8F WH7 WHG WOQ X7M X7N XOL Y6R ZGI ZXP ~A~ - 08R 0R 55 A AAPBV ABFLS ADACO ADBIT AFMIJ BXI GJ HZ ZA5 AAYXX CITATION 5PM |
ID | FETCH-LOGICAL-a3518-3b2ed30c9314f56f7e307e1753efbf0c7b37c1c583005e6035017b5f5b089833 |
IEDL.DBID | RPM |
ISSN | 0066-4804 |
IngestDate | Tue Sep 17 21:23:24 EDT 2024 Thu Sep 12 17:51:43 EDT 2024 Tue Dec 28 13:59:02 EST 2021 Sat Sep 28 08:42:42 EDT 2024 Wed May 18 15:29:03 EDT 2016 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a3518-3b2ed30c9314f56f7e307e1753efbf0c7b37c1c583005e6035017b5f5b089833 |
OpenAccessLink | https://aac.asm.org/content/aac/16/2/158.full.pdf |
PMID | 485126 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_352813 highwire_asm_aac_16_2_158 crossref_primary_10_1128_AAC_16_2_158 pubmed_primary_485126 asm2_journals_10_1128_AAC_16_2_158 |
PublicationCentury | 1900 |
PublicationDate | 19790801 |
PublicationDateYYYYMMDD | 1979-08-01 |
PublicationDate_xml | – month: 8 year: 1979 text: 19790801 day: 1 |
PublicationDecade | 1970 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Antimicrobial Agents and Chemotherapy |
PublicationTitleAlternate | Antimicrob Agents Chemother |
PublicationYear | 1979 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
SSID | ssj0006590 |
Score | 1.3200088 |
Snippet | Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit... Several 5-alkyl derivatives of 1-beta-d-arabinofuranosyluracil (araU) were tested for antiherpesviral activity and inhibitory action on cell growth in human... Several 5-alkyl derivatives of 1-β-d-arabinofuranosyluracil (araU) were tested for antiherpesviral activity and inhibitory action on cell growth in human... Several 5-alkyl derivatives of 1-β- d -arabinofuranosyluracil (araU) were tested for antiherpesviral activity and inhibitory action on cell growth in human... |
SourceID | pubmedcentral crossref asm2 pubmed highwire |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 158 |
SubjectTerms | Arabinofuranosyluracil Arabinofuranosyluracil - analogs & derivatives Arabinofuranosyluracil - pharmacology Biosynthesis Biosynthesis; Chemistry; Mechanisms of Action and Resistance Cell Division - drug effects Chemistry Cytopathogenic Effect, Viral - drug effects DNA - biosynthesis Herpes Simplex Herpes Simplex - drug therapy Mechanisms of Action and Resistance Thymidine - metabolism Uridine Uridine - analogs & derivatives |
Title | In Vitro Antiherpesviral Activity of 5-Alkyl Derivatives of 1-β-d-Arabinofuranosyluracil |
URI | http://aac.asm.org/content/16/2/158.abstract https://www.ncbi.nlm.nih.gov/pubmed/485126 https://journals.asm.org/doi/10.1128/AAC.16.2.158 https://pubmed.ncbi.nlm.nih.gov/PMC352813 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Bb9MwGLVYBWgXBGWIsjFZCHaa0ziOHecYdZsGUlEPBY1TZDu2FtEmVdMh9W_th_CbZsfJ1h64cI0dJ8r77GfHz-8D4LOleJclLkWUFG6b0VCUcqdxj7Aw2JhQtucrpt_Z9Y_42w296Q6FNZ2sslKyDKrFMqjK21ZbuVqqca8TG8-mE-dIgsn4ABzY-OxX6N3oy6j_r2KpFMU8jHuxe8THWTYJMAuiAFN-CJ7HdrLhPBUGollG-7TUWwXv0NK-ZHKHg65eg1fd5BFm_iXfgGe6GoIXPp3kdgheTruN8iE4m3lL6u05nD-dsGrO4RmcPZlVb9-CX18r-LPcrGuYVZvSVl3pxul-7VOUTywBawMpyha_twt4YeP1T2sV3rjLGP29RwXK1sKur2tzZ3mvbpzQXahycQTmV5fzyTXq0i0gQSjmiMhIFyRUKcGxocwk2vZ_7Zw8tZEmVIkkicKKcudwr1m7JZlIaqgMecoJeQcGVV3p9wAywwoHNuNaxElSSMvEYWHs2KAKmQo1Ap_cN8-77tLk7Uok4rlFKMcsj3KL0Ah86RHJV9554x_1Rj1cuW01F0LtlB152B5b8KCPANuD87HYmW3vl9gYbE23fcx9-N8bj8EhTpPUSwdPwGCzvtMf7XRmI08dmdDTNoofAOrw84c |
link.rule.ids | 230,315,730,783,787,888,27938,27939,53806,53808 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLagXLYXLt0Q5Woh2NOcxknsJI9RYepgnfrQofFkxY4torVJ1aSTys_ih_CbsONka5F4gNccx0l0zvFnx5-_A8B7DfGmSlyMiJ-ZbUZFUBwZjruHU4WVcnlzvmJyTscXwedLctkeCqtaWmUheO4U84VT5N8bbuVyIYYdT2w4nYyMIgn2h3fBPZ2uLu3W6O34S4n9s6LBFAWRG3R0dy8aJsnIwdTxHEyifXA_0NMNo6rQS6uFtwtMnVjwFjDtkia3UOjkMbjo3t-ST66cdc0d8eMPacd__cAn4FE7LYWJtT4Fd2TRBw9socpNHzyctFvwfXA0tWLXm2M4uz27VR3DIzi9lcHeHIBvpwX8mterEiZFneumS1kZRrF-irAlK2CpIEHJ_Gozhx91Jlw3IuSVuYzRr58oQ8kq1Sv3Uq01opaVodCnIp8fgtnJp9lojNpCDij1CY6Qzz2Z-a6IfRwoQlUo9cgijUaoVFy5IuR-KLAgkdHOl7TZ7Aw5UYS7URz5_jPQK8pCPgeQKpqZMKKRTIMwzLjGeDdTetQRGY9TMQDvjC9Zm4gVa9Y4XsS05xmmzGPa8wPwofM0W1pNj7-0G3RhwHSvLE3Flu3QhsNNDzaYBoDuhMmN2ch471q08xs5b-vsF_9741uwN55NztjZ6fmXl2Afx2FsCYqvQK9ereVrPWmq-ZsmR34DPf8UbQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFL0aBaa98FGG6PiKEOxpTuIkTpzHqKPagE59KGh7smInFtHapGpSpO5n8UP4Tdhxs7VIvOw1dhxZ914fO_f4XICPCuJ1lbgYET_TaUZJUEw1x93DqcRSury9XzG-CM--B18uyeUe0O4uTEvaF7ywy9ncLoufLbdyMRdOxxNzJuOhViTBvrPIpPMAHqqQdWl3Tt-swSExf1cUoKKAukFHefeokyRDG4e2Z2NCD-BRoLYcWlmhl9ZzbxecOsHgLXDaJU5uIdHoKVx1czAElGt71XBb3Pwj73ifST6DJ5vtqZWYHs9hLy_78NgUrFz3YX-8ScX34XhiRK_XJ9b07g5XfWIdW5M7Oez1C7g6L60fRbOsrKRsCtV1kdeaWay-IkzpCquSFkHJ7Ho9s05VRPxqxchr_RijP79RhpJlqk7wlVwpZK1qTaVPRTE7hOno83R4hjYFHVDqE0yRz708810R-ziQJJRRrlaYXGuF5pJLV0TcjwQWhGoN_Txsk54RJ5Jwl8bU919Cr6zK_BVYoQwz7U4hzdMgijKusN7NpFp9RMbjVAzgg7Yn2wRkzdqzjkeZsj7DIfOYsv4APnXWZguj7fGffoPOFZgalaWp2Go7NC5xO4JxqAGEO65y26zlvHdblAO0st7G4Ef3ffE97E9OR-zb-cXX13CA4yg2PMU30GuWq_yt2js1_F0bJn8B7y8W7Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+Vitro+Antiherpesviral+Activity+of+5-Alkyl+Derivatives+of+1-%CE%B2-d-Arabinofuranosyluracil&rft.jtitle=Antimicrobial+agents+and+chemotherapy&rft.au=Machida%2C+Haruhiko&rft.au=Sakata%2C+Shinji&rft.au=Kuninaka%2C+Akira&rft.au=Yoshino%2C+Hiroshi&rft.date=1979-08-01&rft.issn=0066-4804&rft.eissn=1098-6596&rft.volume=16&rft.issue=2&rft.spage=158&rft.epage=163&rft_id=info:doi/10.1128%2FAAC.16.2.158&rft.externalDocID=10.1128%2FAAC.16.2.158 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0066-4804&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0066-4804&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0066-4804&client=summon |